##  [Novartis' heart failure medicine LCZ696 granted FDA priority review](/us-en/news/media-releases/novartis-heart-failure-medicine-lcz696-granted-fda-priority-review-0 "Novartis' heart failure medicine LCZ696 granted FDA priority review") 

  Feb 13, 2015